Literature DB >> 22087431

Pathogenesis of Interstitial Lung Disease in Children and Adults.

Stephan W Glasser, William D Hardie, James S Hagood.   

Abstract

Interstitial lung diseases (ILDs) occur across the lifespan, from birth to advanced age. However, the causes, clinical manifestations, histopathology, and management of ILD differ greatly among infants, older children, and adults. The historical approach of classifying childhood ILD (chILD) using adult classification schemes may therefore have done more harm than good. Nevertheless, identification of novel forms of chILD in the past decade, such as surfactant metabolism dysfunction disorders and neuroendocrine cell hyperplasia of infancy (NEHI), as well as genomic analysis of adult ILDs, has taught us that identical genotypes may result in distinct phenotypes at different ages and developmental stages, and that lung developmental pathways and cellular phenotypes are often recapitulated in adult ILDs. Thus comparison of the pathophysiology of ILD in children and adults in the context of lung development is useful in understanding the pathogenesis of these disorders, and may lead to novel therapeutic interventions for ILDs at all ages.

Entities:  

Year:  2010        PMID: 22087431      PMCID: PMC3207223          DOI: 10.1089/ped.2010.0004

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  51 in total

Review 1.  Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process?

Authors:  F Demayo; P Minoo; C G Plopper; L Schuger; J Shannon; J S Torday
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09       Impact factor: 5.464

2.  Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

Authors:  William E Lawson; Peter F Crossno; Vasiliy V Polosukhin; Juan Roldan; Dong-Sheng Cheng; Kirk B Lane; Thomas R Blackwell; Carol Xu; Cheryl Markin; Lorraine B Ware; Geraldine G Miller; James E Loyd; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-04       Impact factor: 5.464

Review 3.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Immunogold EM localization of neurochemicals in human pulmonary neuroendocrine cells.

Authors:  M T Stahlman; M E Gray
Journal:  Microsc Res Tech       Date:  1997-04-01       Impact factor: 2.769

5.  Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF.

Authors:  W E Lawson; S W Grant; V Ambrosini; K E Womble; E P Dawson; K B Lane; C Markin; E Renzoni; P Lympany; A Q Thomas; J Roldan; T A Scott; T S Blackwell; J A Phillips; J E Loyd; R M du Bois
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

6.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

7.  Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts.

Authors:  Valérie Besnard; Susan E Wert; Mildred T Stahlman; Anthony D Postle; Yan Xu; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  Mesenchyme specifies epithelial differentiation in reciprocal recombinants of embryonic lung and trachea.

Authors:  J M Shannon; L D Nielsen; S A Gebb; S H Randell
Journal:  Dev Dyn       Date:  1998-08       Impact factor: 3.780

9.  Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Nobuya Inagaki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

10.  Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung.

Authors:  Enid R Neptune; Megan Podowski; Carla Calvi; Jang-Hyeon Cho; Joe G N Garcia; Rubin Tuder; R Ilona Linnoila; Ming-Jer Tsai; Harry C Dietz
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

View more
  4 in total

1.  Expanding Our Understanding of Children's Interstitial Lung Disease.

Authors:  Robin R Deterding
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 2.  Immune-Related Adverse Events: Pneumonitis.

Authors:  Linda Zhong; Mehmet Altan; Vickie R Shannon; Ajay Sheshadri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Xeroderma Pigmentosum-Associated Childhood Interstitial Lung Disease.

Authors:  Samiksha Kamble; Ketaki Utpat; Unnati Desai; Jyotsna Joshi; Ramesh Bharmal
Journal:  Turk Thorac J       Date:  2022-03

4.  The role of high-resolution chest CT in the diagnosis of neuroendocrine cell hyperplasia of infancy - A rare form of pediatric interstitial lung disease.

Authors:  Julia Lee; Thomas Ray Sanchez; Yanhong Zhang; Sanjay Jhawar
Journal:  Respir Med Case Rep       Date:  2015-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.